FDA Commissioner Scott Gottlieb, MD, announced his resigation effective 1 month from Tuesday, March 5, according to an HHS press release.
The HHS release lauded Gottlieb’s reign as head of the FDA.
"Scott’s leadership inspired historic results from the FDA team, which delivered record approvals of both innovative treatments and affordable generic drugs, while advancing important policies to confront opioid addiction, tobacco and youth e-cigarette use, chronic disease, and more. The public health of our country is better off for the work Scott and the entire FDA team have done over
Uncategorized